Melissa Moore-Clingenpeel

Director of Biostatistics for Phamacovigilance
CorEvitas, United States

Disclosure information not submitted.

Presentation(s):

• 4G-03 - Comparison of Propensity Score Matching vs. Inverse Probability Treatment Weighting: A Simulation Study in the CorEvitas Psoriasis Registry

  Monday, August 25, 2025
  4:45 PM - 5:00 PM ET

• 6F-05 - Comparison of Performance of Common Exposure Episode Definitions in Long-Latency Outcome Studies

  Tuesday, August 26, 2025
  2:30 PM - 2:45 PM ET